THE DOSE OF ICS IN TRIPLE ICS/LABA/LAMA FDC MODULATES INFLAMMATION IN A HUMAN EX VIVO MODEL OF SEVERE EOSINOPHILIC ASTHMA

被引：0
|
作者：
Rogliani, Paola
Ora, Josuel
Motta, Enrico
Laitano, Rossella
Calzetta, Luigino
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.3186
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：4918A / 4918A
页数：1
相关论文
共 32 条
  • [21] Benralizumab: Effectiveness in Patients with Uncontrolled Severe Eosinophilic Asthma at 6 and 12 Months at a Third-Level Care Hospital. Capacity for ICS-LABA Therapy Reduction
    Gonzalez-Tuyub, Yair Humberto
    Gonzalez-Iniguez, Karla Daniela
    Lizarazo-Guiza, Paula Catalina
    Garcia-Garcia, Sergio Ricardo
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 1141 - 1149
  • [22] An ex vivo model of severe asthma using reconstituted human bronchial epithelium
    Gras, Delphine
    Bourdin, Arnaud
    Vachier, Isabelle
    de Senneville, Laure
    Bonnans, Caroline
    Chanez, Pascal
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (05) : 1259 - +
  • [23] Enabling Reductions in Maintenance ICS/LABA Therapy Using as Needed Anti-Inflammatory Reliever for Patients with Severe Eosinophilic Asthma Controlled with Benralizumab: SHAMAL Phase IV Clinical Study
    Jackson, D. J.
    Kent, B. D.
    Humbert, M.
    Heaney, L. G.
    Korn, S.
    Keith, M.
    Siddiqui, S.
    Cook, B.
    Garcia Gil, E.
    Miller, A. de Giorgio
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [24] Enabling Reductions in Maintenance ICS/LABA Therapy Using As Needed Anti-Inflammatory Reliever for Patients with Severe Eosinophilic Asthma Controlled with Benralizumab: SHAMAL Phase IV Clinical Study
    Jackson, Dj
    Kent, B. D.
    Humbert, M.
    Heaney, L. G.
    Korn, S.
    Keith, M.
    Siddiqui, S.
    Cook, B.
    Gil, E. G.
    Miller, de Giorgio A.
    PNEUMOLOGIE, 2021, 75 : S32 - S32
  • [25] BNT162b2 mRNA Covid-19 Vaccine Increases the Sensitivity to Histamine in a Human Ex Vivo Model of Severe Eosinophilic Asthma
    Calzetta, L.
    Chetta, A.
    Aiello, M.
    Frizzellli, A.
    Ora, J.
    Ippoliti, L.
    Magrini, A.
    Rogliani, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [26] BNT162b2 mRNA Covid-19 Vaccine Increases the Contractility to Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma
    Calzetta, L.
    Chetta, A.
    Aiello, M.
    Frizzelli, A.
    Ora, J.
    Ippoliti, L.
    Magrini, A.
    Rogliani, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [27] Pharmacological characterization of the protective effect of benralizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
    Rogliani, Paola
    Matera, Maria Gabriella
    Cavalli, Francesco
    Facciolo, Francesco
    Cazzola, Mario
    Calzetta, Luigino
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [28] Pharmacological characterization of the protective effect of mepolizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
    Calzetta, Luigino
    Matera, Maria Gabriella
    Cavalli, Francesco
    Facciolo, Francesco
    Cazzola, Mario
    Rogliani, Paola
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [29] The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma
    Calzetta, Luigino
    Chetta, Alfredo
    Aiello, Marina
    Frizzelli, Annalisa
    Ora, Josuel
    Melis, Enrico
    Facciolo, Francesco
    Ippoliti, Lorenzo
    Magrini, Andrea
    Rogliani, Paola
    VACCINES, 2023, 11 (02)
  • [30] Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
    Ferguson, Gary T.
    Darken, Patrick
    Ballal, Shaila
    Siddiqui, Mohd Kashif
    Singh, Barinder
    Attri, Sumeet
    Holmgren, Ulf
    de Nigris, Enrico
    ADVANCES IN THERAPY, 2020, 37 (06) : 2956 - 2975
1234